These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27569671)

  • 21. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician.
    Mookadam M; Shamoun FE; Mookadam F
    J Am Board Fam Med; 2015; 28(4):510-22. PubMed ID: 26152444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
    Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
    Hussein A; Saliba W; Wazni OM
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S11-6. PubMed ID: 26694887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients.
    Lai CL; Chen HM; Liao MT; Lin TT; Chan KA
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
    Kasmeridis C; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Hsueh YH; Izem R; Southworth MR; Wei Y; Liao J; Goulding MR; Mott K; Chillarige Y; MaCurdy TE; Worrall C; Kelman JA
    JAMA Intern Med; 2016 Nov; 176(11):1662-1671. PubMed ID: 27695821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian intersociety consensus on DOAC use in internal medicine.
    Prisco D; Ageno W; Becattini C; D'Angelo A; Davì G; De Cristofaro R; Dentali F; Di Minno G; Falanga A; Gussoni G; Masotti L; Palareti G; Pignatelli P; Santi RM; Santilli F; Silingardi M; Tufano A; Violi F; ; ;
    Intern Emerg Med; 2017 Apr; 12(3):387-406. PubMed ID: 28191610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists.
    Elvira Ruiz G; Caro Martínez C; Flores Blanco PJ; Cerezo Manchado JJ; Albendín Iglesias H; Lova Navarro A; Arregui Montoya F; García Alberola A; Pascual Figal DA; Bailén Lorenzo JL; Manzano-Fernández S
    Eur J Clin Invest; 2019 Oct; 49(10):e13161. PubMed ID: 31449685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L; Capilla Lozano F; Gallego Fuentes R; Buitrago F
    Med Clin (Barc); 2016 Mar; 146(6):280-1. PubMed ID: 26343157
    [No Abstract]   [Full Text] [Related]  

  • 34. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A; Baranchuk A; Redfearn D; Simpson C; Abdollah H; Michael K
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):529-40. PubMed ID: 25843430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
    Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I
    J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Oral Anticoagulants in Cardiac Amyloidosis-Associated Heart Failure and Atrial Fibrillation.
    Mentias A; Alvarez P; Chaudhury P; Nakhla M; Moudgil R; Kanj M; Hanna M; Desai MY
    Am J Cardiol; 2022 Feb; 164():141-143. PubMed ID: 34848050
    [No Abstract]   [Full Text] [Related]  

  • 37. Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
    Jolobe OM
    Br J Hosp Med (Lond); 2017 Jul; 78(7):416. PubMed ID: 28692369
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct oral anticoagulants: a guide for daily practice.
    Fontana P; Robert-Ebadi H; Bounameaux H; Boehlen F; Righini M
    Swiss Med Wkly; 2016; 146():w14286. PubMed ID: 26964028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New - direct oral anticoagulants: actual review].
    Michalcová J; Penka M; Buliková A; Zavřelová J; Štěpařová A
    Vnitr Lek; 2016; 62(10):805-813. PubMed ID: 27900867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the new oral anticoagulants: opportunities and challenges.
    Yeh CH; Hogg K; Weitz JI
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1056-65. PubMed ID: 25792448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.